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Abstract 
 
We present a new initiative and its application, namely the design of molecularly 
imprinted polymers (MIPs) for producing protein crystals which are essential for 
determining high-resolution 3-D structures of proteins. MIPs, also referred to as 
‘smart materials’ are made to contain cavities capable of rebinding protein, thus the 
fingerprint of the protein created on the polymer allows it to serve as an ideal template 
for crystal formation. We have shown that six different MIPs induced crystallization 
of nine proteins, yielding crystals in conditions that do not give crystals otherwise. 
The incorporation of MIPs in screening experiments gave rise to crystalline hits in 8-
10% of the trials for three target proteins. These hits would have been missed using 
other known nucleants. MIPs also facilitated the formation of large single crystals at 
metastable conditions for seven proteins. Moreover, the presence of MIPs has led to 
faster formation of crystals in all cases where crystals would appear eventually and to 
major improvement in diffraction in some cases. The MIPs were effective for their 
cognate proteins and also for other proteins, with size-compatibility being a likely 
criterion for efficacy. Atomic Force Microscopy (AFM) measurements demonstrated 
specific affinity between the MIPs cavities and a protein-functionalised AFM tip, 
corroborating our hypothesis that due to the recognition of proteins by the cavities, 
MIPs can act as nucleation inducing substrates (nucleants) by harnessing the proteins 
themselves as templates.  
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\body 
 
Molecularly imprinted polymers (MIPs) are polymers formed in the presence of a 
molecule that is extracted afterwards, thus leaving complementary cavities (or ghost-
sites) behind. The molecular imprint remains as a memory effect in the gel after the 
molecule is removed, and the cavities exhibit highly selective rebinding of the given 
molecule (1, 2).    
 
MIPs were initially used for separation and purification of small molecules such as 
enantio separation of racemic mixtures in chiral compounds (3), separation of 
carbohydrate derivatives (4) and in thin layer chromatography (5). More recently 
MIPs have become an important tool in the preparation of artificial recognition 
materials that are capable of mimicking natural systems (6, 7). In the context of 
proteins, MIPs have been used for protein purification/isolation applications (8), 
replacement of biological antibodies in immunoassays (9 and refs therein), catalysis 
(10) and biosensors for medicine (7 and refs therein). MIPs however, have never 
before been used to facilitate protein crystallization.  
 
This study presents a new approach to the use of MIPs by harnessing them as surfaces 
for inducing the formation of protein crystals. Protein crystallization is vital to the 
success of structural biology as well as structural genomics/proteomics projects 
worldwide that have set out to determine the structures of more than 100,000 
proteins. Obtaining useful crystals remains a major bottleneck to progress (11), thus it 
is crucial to design new and improved means of producing the desired crystals.   
 
The ultimate way to obtain high quality crystals is to control their conception stage, 
namely their nucleation, which is the first step that determines the entire 
crystallization process (12). Once nucleated, crystal growth is optimal at metastable 
conditions, where crystals do not nucleate spontaneously but existing nuclei will grow 
in a controlled manner that will minimize structural defects. Crystallization at 
metastable conditions can be induced by inserting crystal seeds into the trials (e.g. 13) 
however this requires the availability of crystals of the given protein or at least some 
crystalline material to start with. In an ongoing search for alternative heterogeneous 
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seeding materials, a variety of substances such as minerals (14), horse (15) and human 
(16) hair, thin films (17), charged surfaces (18, 19), mesoporous materials (20-22) and 
other materials (23) have been used as nucleants with varied success. The problem 
with such materials is that they are random substances, which have helpful properties 
such as porosity, nanostructure or electrostatic attractive potential, but no designed 
specificity for proteins. Our hypothesis was that MIPs would be very likely to serve as 
ideal nucleants, since they are designed to specifically attract their template protein.  
 
This paper reports crystallization experiments performed with various model and 
target proteins, which demonstrate the effectiveness of MIPs as nucleants for protein 
crystallization. The mechanism of action of MIPs, based on atomic force microscopy 
measurements and on recent work on protein crystal nucleation is also discussed. 
 
 
Results 
 
Crystallization experiments 
 
The MIPs made for this work are referred to as HydroMIPs (hydrogel based MIPs) 
since they are water-based and thus suitable for imprinting biological molecules (see 
Materials and Methods and SI). The HydroMIPs were imprinted with 7 proteins 
namely lysozyme, trypsin, catalase, haemoglobin, intracellular xylanase IXT6-
R217W, alpha crustacyanin and human Macrophage Migration Inhibitory Factor 
(MIF). These will be referred to here as L-MIP, T-MIP, C-MIP, BHb-MIP, IX-MIP, 
AC-MIP and MIF-MIP, respectively. Nucleation inducing properties of the MIPs 
were investigated on 10 proteins. Each MIP was tested for its nucleation inducing 
capability on its own cognate protein as well as on others, as detailed in Tables 1, 2 
and below. For every MIP created, a non-imprinted polymer (NIP) was also produced 
using the same procedure but without the protein template, in order to serve as a 
control for the MIP. Additional controls without any polymer were also set up. 
 
Table 1 shows the results of experiments performed at metastable conditions. The 
crystallization conditions are detailed in SI Materials and Methods. 
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Complex of HIV proteins: Trials in the presence of L-MIP produced crystals that 
diffracted up to 4.2 Å. Previous attempts to crystallize this complex using 
conventional and non conventional methods, as well as known nucleating agents, had 
failed to produce crystals with diffraction beyond 9Å. T-MIP also produced crystals 
but not as well diffracting as the L-MIP.  
Human MIF: crystals formed within 8 days at 1.15 M ammonium sulfate in the 
presence of MIF-MIP, L-MIP and T-MIP (Figure 1). All other trials remained clear 
for at least two months. At 1.10 M ammonium sulfate and below, all drops remained 
clear. At 1.20 M ammonium sulfate, drops with NIPs also gave crystals but the 
controls remained clear. At 1.25 M ammonium sulfate and above, all trials produced 
crystals, with crystals appearing faster in the drops containing MIPs. The crystals 
grown with MIF-MIP and T-MIP diffracted X-rays to a resolution of 1.2 Å using a 
rotating anode X-ray source. Previously, synchrotron sources were necessary to 
achieve the same resolution. 
RECQ1: yielded crystals, the first appearing within two days, at 15% (w/v) PEG 
3350, only in the presence of T-MIP. At 14% (w/v) PEG all trials remained clear for 
at least 3 weeks. At 16% (w/v) PEG 3350, drops with NIP also gave crystals after four 
days with the controls and drops containing L-MIP remaining clear. At 17% (w/v) 
PEG and above, all trials gave crystals. The ones with MIPs were obtained faster. The 
diffraction resolution limit of crystals grown in the presence of MIPS was 2.0Å 
compared with 2.3Å of crystals grown without MIPs.  
Lysozyme: crystals formed within four days at 2.8% (w/v) sodium chloride only in 
the presence of L-MIP and T-MIP, but not in the presence of the other MIPs, NIP or 
in the controls. Below the metastable conditions at 2.7% (w/v) sodium chloride, all 
trials remained clear for at least six weeks after set up. At 2.9% (w/v), controls 
remained clear and drops with NIP also yielded crystals a day after the ones with 
MIP. At 3% (w/v) sodium chloride and above, which are labile conditions, all drops 
gave crystals, albeit sooner with the MIPs.  The diffraction resolution limit of crystals 
grown in the presence of MIPS was 1.5Å compared with 1.5Å of crystals grown 
without MIPs.  
 
Trypsin: crystals formed within 7 days at 13% (w/v) PEG 8000, 0.2 M ammonium 
sulphate and 0.1 M sodium cacodylate at pH 6.5 only in the presence of T-MIP. 
Crystals also formed at 14% in the presence of T-MIP and L-MIP, but not in the 
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presence of the other MIPs, NIP or in the controls. At 12% (w/v) PEG all drops 
remained clear and at 15% and above all trials gave crystals with crystals appearing 
faster in the drops containing the MIPs. The diffraction resolution limit of crystals 
grown in the presence of MIPS was 1.5Å compared with 2.3Å of crystals grown 
without MIPs.  
Thaumatin: crystals formed within 1 to 5 days at 0.3 M and 0.4 M sodium/potassium 
tartrate only in the presence of L-MIP and T-MIP. At 0.2 M Na/K tartrate, all trials 
remained clear for at least 4 weeks. All trials gave crystals at 0.5 M Na/K tartrate and 
above, albeit later in the controls. The diffraction resolution limit of crystals grown 
with MIPS was 1.5Å compared with 1.9Å of crystals grown without MIPs.  
Haemoglobin: crystals formed within 5 days at 22.5% (w/v) PEG 3350 only in the 
presence of the BHb-MIP. At 20% (w/v) PEG 3350, all drops remained clear while at 
25% (w/v) PEG 3350 all drops yielded crystals. In the controls and the drops 
containing NIPS they appeared after 7 days The diffraction resolution limit of crystals 
grown with MIPS was 2.8Å compared with 3.2Å of crystals grown without MIPs.  
 
The X-ray diffraction patterns of crystals grown in drops containing the MIPs showed 
that these crystals diffracted to resolutions equivalent to their expected resolution or 
better, compared to their respective controls, demonstrating that the MIPs do not 
interfere with diffraction quality.   
 
Catalase did not show any nucleation-inducing effect from L-MIP, T-MIP, C-MIP or 
NIP. The nucleation of catalase was actually reduced by its own cognate MIP and to 
some extent by other MIPs as well. 
 
Catalase is a special case. Its own cognate MIP inhibits nucleation although in some 
cases it sped up the nucleation of other proteins. Catalase crystallises via a different 
route, first precipitating with crystals forming later out of the precipitate. Catalase-
imprinted polymer reduces the precipitation to levels that are not sufficient for crystal 
growth at lower supersaturations, possibly by excessively depleting the catalase 
solution. This has been corroborated by spectrophotometric measurements at 280 nm 
of the concentration of protein a few hours after setup at metastable conditions, in 
drops containing T-MIP, C-MIP and in controls. The concentration of protein was 
highest in controls (3.56 mg/ml), marginally lower in drops containing T-MIP (3.38 
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mg/ml) and appreciably lower in the presence of C-MIP (2.99 mg/ml). At higher 
supersaturations, C-MIP allows crystal growth when precipitation is already too 
heavy for crystallization without its presence. Other MIPs do not seem to promote 
catalase nucleation. This may be due to the much higher size of the catalase molecule, 
making it a far worse binder to non-cognate MIPs, which thus neither promote nor 
inhibit its nucleation. 
 
In order to compare the nucleation inducing capability of MIPs with other known 
nucleants, experiments were repeated at the same conditions in the presence of human 
hair, horse hair, zeolites and bioglass powder. No crystals were obtained in any of the 
trials containing these nucleants other than for lysozyme and trypsin which at these 
conditions produced small crystals in the presence of human hair, horse hair and the 
bioglass powder. The crystals obtained however, were multiple and small compared 
to large single crystals which appeared in the drops containing MIPs. 
 
Figure 2 shows how the crystals often evolve from the MIP. Initially the drops with 
MIP are clear, after which there is a sequence of events: (i) first a separation of liquid 
phases occurs, forming protein-rich droplets on the MIP, which can reach a diameter 
of ca. 100 μm (Fig. 2a); (ii) after 6 days, crystalline aggregation is observed in these 
droplets (Fig. 2b); (iii) After 24 hours single, large and well-diffracting crystals 
appear from these protein-rich areas (Fig. 2b).  The time of observing crystalline 
aggregation depends on the protein; for lysozyme and REQ1 for example, the 
equivalent times were three days and one day respectively.   
 
The application of MIPs for screening experiments 
 
In order to test whether MIPs would also be effective in finding new hits during 
initial screening, 4 proteins were screened in the presence and in the absence of their 
cognate MIPs.  These encompassed 3 target proteins (alpha crustacyanin, MIF and 
intracellular xylanase IXT6-R217W) and one model (trypsin). The Index screen was 
chosen for this investigation because it is a popular diverse reagent crystallization 
screen which is widely used. The above mentioned target proteins were selected since 
two of them have not produced useful crystals to date and the third (MIF) requires 
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higher resolution crystals. The fourth, trypsin, which crystallises with relative ease, 
was included to act as a comparison.  
 
Experiments using solutions 1-48 of the Index screen gave 4 to 5 hits for each of the 3 
target proteins when their cognate MIPS were present (Table 2), whereas no hits were 
obtained in their absence. 4 hits were obtained in the case of alpha crustacyanin and 5 
hits were attained for intracellular xylanase IXT6-R217W and MIF.  In the case of 
trypsin the same 2 solutions produced hits with and without MIP. Only conditions 
which had crystals or crystallites were considered as hits (Figure 3a, 3b). The hits 
appeared between 24 hours and 4 days after setting up the trials. Control drops (i.e. 
without MIPs and drops containing NIPs) did not produce any hits after 4 weeks and 
beyond.  Other known nucleants such as human hair (Fig. S1A), zeolites (Fig. S1B), 
horse hair and bioglass powder were tested at the conditions that gave hits with MIPs. 
Except in the case of trypsin these did not produce any hits after 4 weeks either. 
 
The results demonstrate that in the presence of MIPs, 8-10% of the screening trials of 
the target proteins produced hits which would have been missed even when other 
nucleants were applied.  
 
Additional trials were set up to see if non cognate MIPs would also give rise to the 
hits (Table 2). T-MIP and L-MIP were added to screening trials at the conditions that 
gave hits for the 3 target proteins and in the case of alpha crustacyanin, C-MIP was 
applied in addition to T-MIP and L-MIP due to the high molecular weight (320 kDa) 
of this protein. In the case of MIF, 2 hits were obtained with L-MIP and 3 hits with T-
MIP. Intracellular xylanase IXT6-R217W produced 1 hit with T-MIP, and, as 
expected, no hits were obtained for alpha crustacyanin with these MIPs. The 
screening results are commensurate with those at metastable conditions in that MIPs 
of compatible size to the protein also give hits, albeit not as many as the cognate 
MIPs. 
 
In order to test whether raising the concentration of the proteins would produce the 
hits without MIPs, all the trials which yielded hits were set up using 15- 30% higher 
concentrations of MIF and alpha crustacyanin. (The intracellular xylanase IXT6-
R217W could not be concentrated above 8mg/ml, the concentration that was applied 
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for the experiments). Screening with the higher concentrations of the two former 
proteins led to heavy precipitation meaning that the MIPs were not only revealing hits 
which would have been otherwise missed, but also achieving this while consuming 
significantly lower concentrations of the proteins. 
 
AFM Binding Measurements 
 
The results above demonstrate that our hypothesis that MIPs would work as nucleants 
has materialized. To test this beyond the practical evidence of crystallization, atomic 
force measurements were performed to assess affinity of protein to the MIPs and 
compare it with affinity to NIP and also to a polylysine control surface. 
 
In a study totally unrelated to protein crystallization, El Kirat et al. (24) have recently 
shown that atomic force spectroscopy could be used to probe polyacrylamide based 
MIPs used for cytochrome c imprinting of thin film MIPs attached to a mica surface.  
The atomic force measurements of the MIPs in our study were on the bulk gel MIPs 
that were used for the crystallization experiments (described in SI Materials and 
Methods). Non-imprinted polymer (NIP) and bovine haemoglobin (BHb) imprinted 
polymer were tested and a polylysine-coated coverslip acted as a control. 
 
Figure 4 details representative force curves that were generated as a result of 
interactions that occurred between the AFM probes with BHb attached and the MIP 
sample. This is given as an exemplar figure of the hysteresis observed during the 
approach and retraction of the protein modified AFM tip onto the MIP surface. Force 
curves for NIP exhibited similar profiles and only differed in the force value. The 
distinctive, single peaked retraction curve displayed suggests that a single type of 
host-guest binding event is occurring.  
 
One of the most powerful ways in which a MIP effect can be defined, is in relation to 
a NIP prepared in an identical manner to that of the MIP, but in the absence of the 
template molecule. For a given polymer surface, the repeat adhesion events were 
found to have a narrow force distribution about the mean force measured. We were 
able to discriminate between each polymer surface based on the force distributions 
recorded.  A distinctive trend was observed.  The polylysine control exhibited the 
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smallest force, with a (mean) value of 13.51 nN (standard deviation ± 0.38) required 
to remove the AFM probe from the surface.  A somewhat greater force of 18.90 nN (± 
0.31) was required to withdraw the probe from the NIP surface.  The increase in 
attractive forces exhibited between the two samples can be attributed to the BHb 
showing a greater affinity to the polyacrylamide than to the polylysine. Most 
significantly, a force of 23.08 nN (± 0.31) was required to withdraw the template-
modified AFM tip from the cavity-containing MIP sample.  This indicates that 
binding between these sites and the BHb molecule was occurring, which in turn 
resulted in a greater force being required to withdraw the tip from the sample. 
Literature values for single protein-pulling experiments typically show force values of 
400-600 pN (25). Our values are significantly greater due to the cryogenic mode of 
preparation of the MIP and control samples. This was required in order to stabilise the 
hydrogel surfaces. The cryogenic preparation allows the surface to be frozen and the 
difference between the MIP and control surface remains the presence of cavities in the 
former and their absence in the latter. The results show that there is a stronger force of 
attraction between cognate protein-modified tip and MIP surface compared with 
control surfaces. The narrow standard deviation about the mean value measured for 
each surface adds further assurance that MIPs are behaving differently to control 
surfaces. It can therefore be concluded that highly specific interactions were 
reproducibly occurring with each sample investigated using this technique.   
 
Discussion  
 
It has been shown that crystal nucleation may proceed in two steps, namely 
aggregation of molecules into a dense fluid droplet and then ordering. This lowers the 
height of the energy barrier for nucleation: instead of a single, steep energy barrier 
which would occur if ordering of the molecules happened at the same time as their 
aggregation (the classical nucleation model), we would have two lower barriers if the 
two processes happened separately and in succession. We now have direct evidence 
of this mechanism, which ten Wolde & Frenkel (26) showed by simulation studies, 
Lutsko & Nicolis (27) by theoretical considerations and Vekilov (28, 29) by a variety 
of experimental and theoretical approaches. It seems that the MIPs, soon after their 
insertion (overnight for the cases of lysozyme, trypsin and RECQ1), promote 
 11
aggregation of protein molecules, forming a protein-rich phase, which at a later stage 
becomes crystalline (Figure 2). 
 
It therefore appears that in these cases, MIPs may function by facilitating the 
nucleation and stabilisation of droplets of the protein-rich liquid phase, at conditions 
which would be quite far from the liquid-liquid phase separation conditions in the 
absence of nucleant (i.e. in the bulk). 
 
Lysozyme is one of very few proteins for which quantitative liquid-liquid demixing 
data has been obtained (30). From that data, it appears that liquid-liquid phase 
separation at 20 mg/ml lysozyme in sodium acetate buffer at pH 4.5 and 20°C (our 
conditions) requires at least 7 %(w/v) NaCl, instead of the 2.8 %(w/v) at which 
nucleation of protein-rich droplets and subsequently of crystals occurs in this study in 
the presence of MIP. The liquid-liquid demixing curve obtained at a concentration of 
3 %(w/v) NaCl by Muschol & Rosenberger (30) gets very close to 0°C for 20 mg/ml 
lysozyme. 
 
No quantitative liquid-liquid demixing data exists for the other proteins in this study. 
However, no visible droplets or clouding of the drops could be observed under the 
microscope at any time during the experiments in the absence of MIP, not only at 
metastable conditions but also well within the spontaneous nucleation zone of 
conditions. This qualitatively supports the general structure of a globular protein 
phase diagram proposed by Muschol & Rosenberger (30) and by Asherie (31), who 
place the liquid-liquid demixing curve in the bulk well beyond (at much higher 
supersaturations than) the solubility curve. 
 
The MIP cavities, although they have a well-defined shape, are randomly dispersed 
through the gel. They therefore cannot induce the protein molecules to orient 
themselves in a specific pattern, i.e. providing a surface for epitaxial growth. It seems 
however, that the MIP can pull together a sufficient number of those molecules in 
order to overcome the energy barrier for the first step of forming a (yet disordered) 
precursor. The fabrication method is such that we expect a very high density of 
cavities due to the abundance of protein mixed with the monomer, making isolation 
of the cavities unlikely. The second step, ordering of the nucleus, may be aided by 
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immobilised protein molecules in the cavities attracting further protein molecules. If 
the attractive forces between immobilised protein and protein in solution are similar 
in magnitude to the protein-polymer forces, then re-arrangement of the assembled 
molecules to form ordered nuclei becomes possible in spite of the disorder in the 
cavities’ orientations.   
  
Another explanation of the effectiveness of the cavities that are not oriented in a way 
directly conducive to proper crystal packing, is the possibility of a statistical effect 
with only a few of the cavities in favourable mutual orientations. Various studies (32, 
33) have shown that a very small number (less than 12) of macromolecules can be 
sufficient for the formation of a critical nucleus. This explanation is supported by the 
results, showing crystals forming on some parts of the MIP and not throughout it. 
This is actually an advantage, because we desire one or few crystals, rather than 
many. It may well be that there is a combination of the statistical effect with the 
lowering of the energy barrier. 
 
An issue which may arise is that the imprints will be single isolated receptor sites, 
many of which will be partially or wholly buried in the polymer structure, thus not 
allowing the protein molecules to access them and also preventing the crystals from 
growing due to lack of space. Indeed, some of the pores will be buried due to the 
nature of the imprinting procedure. But, for the purpose of protein nucleation it does 
not matter that some are buried since only a few pores are needed at the surface for 
nucleation to occur. In order to ensure that some of the pores are on the surface, the 
imprinted hydrogels are broken into smaller particles thereby exposing cavities on the 
particle surface.  
 
In summary, AFM results demonstrate that there is a definite binding of protein to the 
cavities of the MIPs and less so to the NIPs. The crystallization results follow this 
pattern, showing that in the presence of MIPs (i) crystals are formed in conditions that 
do not give crystals otherwise and (ii) crystals form faster in conditions which will 
produce crystals eventually. For crystals to grow in the presence of NIPs the 
crystallization conditions need to be at a higher supersaturation than in the presence of 
MIPs, thereby yielding poorer quality crystals. 
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We have demonstrated that MIP nucleants can be used in two ways: (i) as a 
heterogeneous seed for growing crystals in the metastable zone of the crystallization 
phase diagram, where crystals do not spontaneously nucleate but can often grow to 
higher quality, and (ii) as an addition to standard screening conditions, where they 
can help to produce hits that would have been missed in their absence. 
 
When embarking on the MIP experiments we expected that each MIP would work 
exclusively on its cognate protein and that it would be necessary to make a MIP for 
each protein to be crystallised. In practice, our results demonstrate that MIPs such as 
those imprinted with lysozyme and trypsin also induced the crystallization of other 
proteins with a molecular weight of the same order of magnitude. These observations 
promise further possibilities than initially envisaged, meaning that a MIP of one 
protein may be successfully used for other, size-compatible proteins. This is very 
important in the case of difficult to crystallise proteins, which are usually too scarce in 
supply for imprinting and would therefore benefit from the use of a related MIP.  
 
The findings of this study open up a new scope for protein crystallization 
corroborating our hypothesis that by harnessing the proteins themselves as templates, 
MIPs are effective nucleation inducing substrates for both the screening and 
optimization stages of crystallization. A patent has been applied for the use of MIPs 
for crystallisation, however this does not preclude any scientific research and 
development of this approach.  
 
Materials and Methods 
 
The materials required for the fabrication of the HydroMIP samples, the reagents 
utilised for the crystallization trials and the information pertaining to the preparation 
of the proteins tested are all documented within the Supporting Information (SI 
Materials and Methods). 
 
HydroMIP fabrication 
 
Traditional MIPs only demonstrate their selectivity when they rebind template in the 
organic solvent in which they were synthesised (34). These methods are therefore 
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unsuitable for imprinting of biomolecules such as proteins, as they are denatured 
under such organic solvent conditions. The MIPs made for this work were therefore 
water-based MIPs, also referred to as hydrogel based MIPs (HydroMIPs). They offer 
a compromise between the polymerisation required for cavity formation and the need 
to keep protein structural integrity during imprinting. HydroMIPs are made of 
polyacrylamide, a nitrogen containing member of the acrylate family of polymers, 
which is a suitable imprinting matrix for biological molecules, as it is water 
compatible, cheap, easily produced and can be derivatised to introduce functional 
groups (namely hydroxyl, carboxylate and amino groups) to better engineer the 
complementary interactions between the template molecule and the polymer (8).  
 
HydroMIPs were prepared following a previously reported procedure (35) and with 
the intention of using as little protein sample as possible and at significantly smaller 
final volumes. For every MIP created, a NIP (non-imprinted polymer) was also 
created using the same material concentration as the MIP but without the protein 
template (SI Materials and Methods). The HydroMIPs and NIPs are translucent and 
have a gel-like appearance and texture.  
 
Crystallization experiments 
 
The MIPS and other nucleants (human hair, horse hair, zeolites VPI-5 and MCM-41, 
crushed glass and bioglass powder) were inserted into crystallization trials set up in 
hanging drops in either EasyXtal toolsTM (Qiagen) or Linbro plates. These drops 
consisted of 1 μl protein solution mixed with 1 μl reservoir solution. 0.2 μl of polymer 
(as a viscous gel) was then dispensed into these drops using a standard micropipette. 
The same polymer but not imprinted with protein (NIP) was also dispensed at the 
same conditions, as a control. An additional control without any polymer was also set 
up. 
 
A simple “working phase diagram” was constructed for each protein (except for 
IXT6-R217W and alpha crustacyanin which were used only for the screening 
experiments) in order to find metastable conditions. Protein concentrations and 
buffers were kept fixed and supersaturation was varied by spanning a range of 
precipitating agent concentrations. It was ensured that a suitable range of conditions, 
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spanning from undersaturation to spontaneous nucleation was being searched in each 
case.  
 
For each protein and each tested condition, trials were set up at the same time from 
the same batch of protein at identical crystallization conditions with MIP imprinted 
with lysozyme (L-MIP), trypsin (T-MIP), catalase (C-MIP), haemoglobin (BHb-
MIP), MIF (MIF-MIP), as well as with NIP and without polymer. Each combination 
was repeated in at least 6 different drops. Detailed methodology and the precise range 
of conditions for each of the proteins are documented in the Supporting Information 
(SI Materials and Methods).  
 
Solutions 1-48 of the Index screen (Cat. No. HR2-144, Hampton Research, USA) 
were used for screening experiments of trypsin, alpha crustacyanin, MIF and 
intracellular xylanase IXT6-R217W (details of the stock protein solutions are given in 
SI Materials and Methods). The experiments were incubated at room temperature (ca. 
22°C) and all trials that gave hits were repeated in at least duplicate to ensure 
reproducibility.   
 
The HIV Complex, RECQ1, thaumatin and trypsin crystals were X-rayed at the 
Diamond Light Source on the MX beamline I04. MIF, lysozyme and haemoglobin 
crystals were X-rayed on the Rigaku 007HF-M X-ray generator at Imperial College 
London, operating at 40 kV and 30 mA, with VHF optics producing a spot size of less 
than 100 microns, Saturn 944+ CCD detector and Oxford Cryosystems 700 liquid 
nitrogen cryostream.   
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Figure Legends 
Figure 1.  
 
MIF crystallization trials in the presence of trypsin-imprinted polymer (T-MIP) and 
the non-imprinted polymer (NIP). The MIP and NIP have a translucent gel-like 
appearance. (a) MIF crystals grown in a drop containing T-MIP. The MIP is indicated 
by the arrow, Scale bar corresponds to 0.1mm (b) Drop containing NIP at identical 
conditions; no crystals are formed. Scale bar corresponds to 0.15 mm. 
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Figure 2.  
 
Progression of the formation of trypsin crystals on trypsin-imprinted MIP. (a) phase 
separation (b) crystalline aggregation at the protein-rich droplets (bottom left) and 
large single crystal. Scale bars correspond to 0.05mm. 
Figure 3. Results of screening with the Index screen. 
(a) a hit containing MIF crystals in solution 5, scale bar corresponds to 0.15mm  (b) a 
hit containing alpha crustacyanin crystals in solution 43, scale bar corresponds to 
0.05mm The color of the alpha crustacyanin protein is blue, hence the  dark color of 
the crystals.   
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Figure 3 
 
 
 
 
Results of screening with the Index screen. (A) A hit containing MIF crystals in 
solution 5, scale bar corresponds to 0.15 mm. (B) A hit containing alpha crustacyanin 
crystals in solution 43, scale bar corresponds to 0.05 mm. The color of the alpha 
crustacyanin protein is blue, hence the dark color of the crystals. 
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Figure 4.  
 
 
A typical force-distance graph detailing the interrogation of MIP with a BHb-
conjugated 10nm (radius of curvature) silicon nitride AFM probe. The grey line 
shows the tip descending, initially without contact with the surface.  At some point, 
the tip jumps into contact with the surface and indents into it.  The black line shows 
the tip retracting: the adhesion/bonding between tip and sample causes the cantilever 
to adhere to the sample.  As the retraction continues the adhesion breaks.  The cycle 
can then be repeated. 
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Table Legends 
 
Table 1. Crystallization results at metastable conditions. Controls consist of the same 
conditions without MIPs or NIPs. 
Protein MW, 
kDa 
L-MIP T-MIP C-
MIP 
MIF-
MIP 
BHb-MIP NIPS Controls 
Human MIF 12.3 crystals crystals — crystals — clear clear 
Lysozyme  14.5 crystals crystals clear clear clear clear clear 
Thaumatin 22 crystals crystals clear clear clear clear clear 
Trypsin 24 clear crystals clear clear clear clear clear 
HIV complex 35.2 crystals crystals clear — clear clear clear 
Haemoglobin 64.5 clear clear — clear crystals clear clear 
RECQ1 67.2 clear crystals — — — clear clear 
Catalase 232 clear clear clear — — clear clear 
 
 
Table 2. Hits obtained in screening trials using MIPs.  represent hits. The hit 
conditions are listed in SI Materials and Methods.  
 
Protein Conc. mg/mL Index screen 
solution 
Cognate MIP L-
MIP 
T-
MIP 
MIF 12.3 kDa 12 4 ✓ ✓ ✓ 
5 ✓ ✓ ✓ 
6 ✓ — — 
8 ✓ — — 
27 ✓ — ✓ 
IXT6R217W 
38.6 kDa 
8 19 ✓ — — 
23 ✓ — ✓ 
26 ✓ — — 
30 ✓ — — 
31 ✓ — — 
Crustacyanin 
320 kDA 
10 41 ✓ — — 
43 ✓ — — 
44 ✓ — — 
46 ✓ — — 
 
